These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4930192)

  • 21. [Sensitivity of dysentery bacteria to furazolidone and phthalazol according to the materials of medical epidemiological station of Odessa-Kishinev railroad].
    Lazareva ZA; Krugliachenko AI; Gol'denberg EI; Evseev IE; Shkoda VF
    Lab Delo; 1976; (2):101-2. PubMed ID: 58090
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experimental study of the effectiveness of antibacterial preparations in treating dysentery].
    Suptel' EA; Zagornaia NB; Bass TM
    Antibiotiki; 1979 Mar; 24(3):207-10. PubMed ID: 156002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of antibacterial drugs in Shigella sonnei infections in childhood].
    Pöhlandt K; Greiner C; Handrick W
    Kinderarztl Prax; 1988 Nov; 56(11):547-50. PubMed ID: 3062230
    [No Abstract]   [Full Text] [Related]  

  • 24. Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy.
    Cheasty T; Day M; Threlfall EJ
    Clin Microbiol Infect; 2004 Nov; 10(11):1033-5. PubMed ID: 15522014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effectiveness of biseptol in the overall treatment of acute sonne and flexner dysenteries].
    Gebesh VV; Vinogradova MD; Sofienko NI; Lysak LI
    Vrach Delo; 1978 Sep; (9):127-31. PubMed ID: 360614
    [No Abstract]   [Full Text] [Related]  

  • 26. [Diagnosis of atypical and asymptomatic forms in Sonnei-dysentery in nurseries].
    Maksimets VG; Kiriengko MS; Gusakova AI
    Pediatr Akus Ginekol; 1970; 6():5-6. PubMed ID: 4933269
    [No Abstract]   [Full Text] [Related]  

  • 27. [Length of stay in the hospital in shigella and salmonella infections treated with furazolidone and without any antimicrobial chemotherapy].
    Nikorowitsch E
    Z Gesamte Inn Med; 1978 Jan; 33(2):51-4. PubMed ID: 636501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. II. An attempt of Shigella sonnei bacteriological negativeness with neomycin.
    Ondrácek J; Bastecká V; Lonská V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1968; 11(3):297-301. PubMed ID: 4890778
    [No Abstract]   [Full Text] [Related]  

  • 29. Geraniol as a novel antivirulence agent against bacillary dysentery-causing Shigella sonnei.
    Mirza ZRMH; Hasan T; Seidel V; Yu J
    Virulence; 2018 Jan; 9(1):450-455. PubMed ID: 29256316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relation of dysentery drug therapy to the development of antibiotic resistance in Shigella].
    Kheĭlik AG; Man'kovskiĭ AV
    Antibiotiki; 1981 Aug; 26(8):606-7. PubMed ID: 7027914
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of combined chloramphenicol and neomycin therapy on the clinical and bacteriological therapy of infantile shigelloses].
    Mirovský J; Dvorský K
    Cas Lek Cesk; 1968 May; 107(21):632-5. PubMed ID: 4871513
    [No Abstract]   [Full Text] [Related]  

  • 32. Therapeutic value of Gramurin (oxolinic acid) in Shigella infections and Shigella-negative dysentery syndrome.
    Münnich D; Lehel F
    Ther Hung; 1990; 38(1):41-3. PubMed ID: 2345905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current aspects of sterilization of carriers of Shigella].
    Procopan V; Struşievici B; Gavrilă I; Suciu O; Ardeleanu R
    Microbiol Parazitol Epidemiol (Bucur); 1969; 14(1):57-64. PubMed ID: 4888809
    [No Abstract]   [Full Text] [Related]  

  • 34. [Furazolidone therapy of infectious diarrheas in children and adults].
    Sziegoleit W; Ehrke D
    Z Gesamte Inn Med; 1968 Jul; 23(13):406-10. PubMed ID: 4878399
    [No Abstract]   [Full Text] [Related]  

  • 35. Emergence of nalidixic acid resistance in Shigella sonnei isolated from patients having acute diarrheal disease: report from eastern province of Saudi Arabia.
    Panhotra BR; Saxena AK; Al-Mulhim K
    Jpn J Infect Dis; 2004 Jun; 57(3):116-8. PubMed ID: 15218222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of bacillary dysentery with Hetacillin (BL-P 804). Preliminary report].
    Totani T; Yamada Y; Amano F
    J Antibiot B; 1967 Apr; 20(2):108-10. PubMed ID: 4861541
    [No Abstract]   [Full Text] [Related]  

  • 37. Shigella sonnei bacteremia. Unusual antibody response from immunosuppressive therapy following renal transplantation.
    Neter E; Merrin C; Surgalla MJ; Wajsman Z
    Urology; 1974 Aug; 4(2):198-200. PubMed ID: 4605112
    [No Abstract]   [Full Text] [Related]  

  • 38. Ampicillin inthe treatment of shigellosis.
    Patton LH; Crawford SE; Inclan AP
    South Med J; 1968 May; 61(5):501-4. PubMed ID: 4869885
    [No Abstract]   [Full Text] [Related]  

  • 39. [Dysentery in Poland in 2001].
    Stypułkowska-Misiurewicz H; Gonera E
    Przegl Epidemiol; 2003; 57(1):77-84. PubMed ID: 12926313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effectiveness of the antibacterial therapy of patients with various forms of dysentery].
    Tumanov FA; Mashilov VP; Iushchuk ND
    Antibiotiki; 1975 Jun; 20(6):556-9. PubMed ID: 131507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.